ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,226,400, issued on Feb. 18, was assigned to UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh).
"Neuroprotective disruption of Kv2.1/syntaxin interaction by small molecules" was invented by Elias Aizenman (Pittsburgh) and Carlos Jaime Camacho (Pittsburgh).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are small molecule compounds capable of disrupting Kv2.1-syntaxin binding. The compounds are useful for treating a variety of neurological disorders, diseases, and injuries."
The patent was filed on July 31, 2019, under Application No. 17/264,982.
*For further information, including images, charts and tab...